Drugs Affecting Blood and Blood Formation Practice Questions

Q: Which of the following drugs inhibits the activation of plasminogen?

Aminocaproic acid. ***Correct Option: Aminocaproic acid*** - **Aminocaproic acid** is an antifibrinolytic drug that acts by competitively inhibiting the activation of **plasminogen** to plasmin. - By preventing the formation of plasmin, it stabilizes blood clots and is used to treat excessive bleeding. *Incorrect Option: Streptokinase* - **Streptokinase** is a **thrombolytic agent** that forms a complex with plasminogen, converting uncomplexed plasminogen into plasmin. - This action promotes the degradation of fibrin clots, making it a **fibrinolytic drug**, not an inhibitor of plasminogen activation. *Incorrect Option: Reteplase* - **Reteplase** is a **recombinant tissue plasminogen activator (tPA)** that directly converts plasminogen to plasmin. - This drug actively promotes **fibrinolysis** and clot breakdown, making it a thrombolytic agent. *Incorrect Option: Clopidogrel* - **Clopidogrel** is an **antiplatelet drug** that inhibits platelet aggregation by irreversibly blocking the P2Y12 adenosine diphosphate (ADP) receptor on platelets. - Its mechanism of action is focused on **platelet function**, not on the plasminogen-plasmin system.

Q: Mechanism of action of tranexamic acid is

Prevents fibrinolysis. ***Correct: Prevents fibrinolysis*** - Tranexamic acid is an **antifibrinolytic agent** that works by inhibiting the activation of plasminogen to plasmin. - By preventing the formation of plasmin, it stabilizes **fibrin clots** and reduces bleeding. *Incorrect: Decrease vascular permeability* - This is primarily the mechanism of action of drugs like antihistamines or corticosteroids, which work on **inflammation** and **allergic reactions**. - Tranexamic acid does not directly target vascular permeability; its primary role is in **hemostasis**. *Incorrect: Smooth muscle contraction* - This describes the action of drugs like **vasoconstrictors** (e.g., epinephrine) or agents that promote uterine contractions (e.g., oxytocin). - Tranexamic acid has no direct effect on **smooth muscle contraction**. *Incorrect: Activates Plasmin formation* - This is the opposite of tranexamic acid's action; drugs that activate plasmin, such as **tissue plasminogen activators (tPAs)**, are used to break down clots. - Tranexamic acid specifically **inhibits plasminogen activation**, thereby preventing plasmin formation.

Q: Which of the following anticoagulants is given orally?

Rivaroxaban. ***Rivaroxaban*** - Rivaroxaban is a **direct oral anticoagulant (DOAC)** that specifically inhibits **Factor Xa**. - It is administered orally and does not require routine coagulation monitoring. *Argatraban* - Argatroban is a **direct thrombin inhibitor (DTI)** primarily used intravenously, especially in patients with **heparin-induced thrombocytopenia (HIT)**. - It is not an orally administered anticoagulant. *Alteplase* - Alteplase is a **thrombolytic agent** (clot buster), not an anticoagulant, that works by converting **plasminogen to plasmin**. - It is administered intravenously to dissolve existing clots. *Fondaparinux* - Fondaparinux is a **synthetic pentasaccharide** that selectively inhibits **Factor Xa** by binding to antithrombin. - It is administered **subcutaneously**, not orally.

Q: Which of the following is a parenteral direct thrombin inhibitor?

Argatroban. ***Argatroban*** - **Argatroban** is a **synthetic direct thrombin inhibitor** administered exclusively via **intravenous infusion**, making it a parenteral drug. - It does not require antithrombin for its action and is primarily used in patients with **heparin-induced thrombocytopenia (HIT)**. *Ximelagatran* - **Ximelagatran** was an **oral direct thrombin inhibitor** but was withdrawn from the market due to concerns about severe **liver toxicity**. - As an oral drug, it is not a parenteral medication. *Dabigatran* - **Dabigatran** is a **direct thrombin inhibitor** that is administered **orally** in capsule form (as dabigatran etexilate, a prodrug). - Therefore, it is not a parenteral medication. *Heparin* - **Heparin** is an **indirect thrombin inhibitor** because it requires binding to **antithrombin** to exert its anticoagulant effect. - Although administered parenterally, its mechanism of action is indirect.

Q: What is Hydroxyethyl starch?

Plasma expander. ***Plasma expander*** - **Hydroxyethyl starch** is a **colloid solution** used intravenously to increase plasma volume and maintain oncotic pressure. - It is often used in situations of **hypovolemia** or shock to support circulation. *Vasodilator* - A **vasodilator** is a medication that widens blood vessels, typically used to lower blood pressure or improve blood flow. - Hydroxyethyl starch does not directly cause **vasodilation** as its primary mechanism of action. *Inotrope* - An **inotrope** is an agent that alters the force or energy of muscular contractions, mainly affecting the heart's contractility. - Hydroxyethyl starch has no direct effect on **myocardial contractility**. *Diuretic* - A **diuretic** is a substance that promotes increased production of urine, thereby increasing the excretion of water from the body. - While fluid administration can temporarily increase urine output, hydroxyethyl starch is not classified as a **diuretic agent** itself.

Q: The best agent for increasing HDL cholesterol is?

Nicotinic acid. ***Nicotinic acid*** - **Nicotinic acid** (niacin) is known to significantly increase **high-density lipoprotein (HDL) cholesterol** levels by reducing its catabolism. - It also has beneficial effects on other lipid parameters, such as lowering **triglycerides** and **LDL cholesterol**. *Statin* - **Statins** (HMG-CoA reductase inhibitors) are highly effective at lowering **LDL cholesterol** and moderately lowering triglycerides. - While they can cause a modest increase in HDL cholesterol, their primary role is not HDL elevation. *Gugulipids* - **Gugulipids**, derived from the gum resin of the _Commiphora mukul_ tree, have been used in traditional medicine to lower cholesterol. - Evidence for their efficacy in significantly increasing HDL cholesterol is weak and not clinically recommended. *Fibrates* - **Fibrates** primarily work to lower **triglyceride levels** and can modestly increase HDL cholesterol. - Their effect on HDL is generally less pronounced compared to nicotinic acid.

Q: Which drug is used as a treatment for sickle cell anemia by promoting fetal hemoglobin production?

Hydroxyurea. ***Hydroxyurea*** - **Hydroxyurea** is the primary drug used to treat sickle cell anemia by promoting **fetal hemoglobin (HbF)** production - It is a **ribonucleotide reductase inhibitor** that increases HbF levels, which reduces sickling of red blood cells - Clinical benefits include reduced frequency of **vaso-occlusive crises**, decreased need for transfusions, and improved survival - Mechanism: Increases **HbF** production, which dilutes the abnormal **HbS** and prevents polymerization *Trypsin* - **Trypsin** is a **proteolytic enzyme** involved in protein digestion in the gastrointestinal tract - It has no role in the treatment of **sickle cell anemia** or in promoting **fetal hemoglobin** production *L-glutamine* - **L-glutamine** is an **amino acid** (not a drug that promotes HbF) approved for sickle cell disease - Its mechanism involves reducing **oxidative stress** by increasing NAD+ levels and improving red blood cell energy metabolism - It reduces complications but does not primarily work by increasing **fetal hemoglobin** production *Glucose 6-phosphate dehydrogenase* - **G6PD** is an **enzyme** in the **pentose phosphate pathway**, not a therapeutic agent - **G6PD deficiency** causes hemolytic anemia but is unrelated to sickle cell disease treatment or fetal hemoglobin production

Q: Low molecular weight heparin mainly inhibits which factor?

Factor Xa. ***Factor Xa*** - Low molecular weight heparin (LMWH) primarily exerts its anticoagulant effect by binding to **antithrombin III** and increasing its inhibitory activity against **Factor Xa**. - This selective inhibition of Factor Xa, rather than Factor IIa (thrombin), accounts for its more predictable anticoagulant response and lower risk of bleeding compared to unfractionated heparin. *Factor VIIIa* - **Factor VIIIa** is a cofactor in the intrinsic pathway, crucial for activating Factor X, but it is not directly inhibited by LMWH. - Its inhibition is more characteristic of **activated protein C**, not LMWH. *Factor XIIa* - **Factor XIIa** is involved in the initiation of the intrinsic coagulation pathway and the kallikrein-kinin system. - LMWH has no significant inhibitory effect on Factor XIIa. *Factor IIa* - While unfractionated heparin inhibits **Factor IIa (thrombin)** relatively equally to Factor Xa, LMWH has a much weaker inhibitory effect on Factor IIa due to its shorter chain length. - The anti-Factor IIa activity of LMWH is generally considered to be negligible compared to its **anti-Factor Xa activity**.

Q: Romiplostim mimics which of the following receptors?

Thrombopoietin. ***Thrombopoietin*** - **Romiplostim** is a **thrombopoietin receptor agonist**, meaning it binds to and activates the **thrombopoietin receptor** [1]. - This activation mimics the effect of endogenous thrombopoietin, stimulating the production of **platelets** in the bone marrow [2].*IL 6* - **Interleukin-6 (IL-6)** is a cytokine involved in inflammation, immune response, and hematopoiesis, but it is not the primary target of romiplostim. - While IL-6 can influence platelet production indirectly, romiplostim directly targets the thrombopoietin pathway.*IL 8* - **Interleukin-8 (IL-8)** is a chemokine primarily involved in neutrophil chemotaxis and inflammation. - It plays no direct role in the mechanism of action of romiplostim.*PGE 1* - **Prostaglandin E1 (PGE1)** is a lipid compound with various effects, including vasodilation and inhibition of platelet aggregation. - Romiplostim's mechanism of action is distinct from that of prostaglandins, as it specifically targets platelet production rather than platelet function or vascular tone.

Q: Which of the following drugs inhibit platelet cyclooxygenase reversibly?

Ibuprofen. ***Ibuprofen*** - Ibuprofen is a non-steroidal anti-inflammatory drug (**NSAID**) that **reversibly inhibits** both **COX-1** and **COX-2** enzymes. - Its inhibitory effect on platelet function is temporary and wears off as the drug is metabolized and cleared from the body. *Alprostadil* - **Alprostadil** is a synthetic **prostaglandin E1 (PGE1)** analogue; it does not inhibit cyclooxygenase. - It works by directly activating **prostaglandin receptors**, leading to vasodilation and inhibition of platelet aggregation. *Aspirin* - **Aspirin** *irreversibly inhibits* platelet cyclooxygenase (specifically **COX-1**) by **acetylation** of a serine residue. - This irreversible inhibition means that the effect on platelets lasts for their entire lifespan, requiring new platelets to be produced for normal function. *Prednisolone* - **Prednisolone** is a **corticosteroid** that works by inhibiting **phospholipase A2**, thereby preventing the release of arachidonic acid, the precursor for prostaglandins. - It does not directly inhibit cyclooxygenase enzymes, but rather acts upstream in the inflammatory pathway.

Question 1

Which of the following drugs inhibits the activation of plasminogen?

Accepted Answer

Aminocaproic acid

Answer

Streptokinase

Answer

Reteplase

Answer

Clopidogrel

Question 2

Mechanism of action of tranexamic acid is

Accepted Answer

Prevents fibrinolysis

Answer

Decrease vascular permeability

Answer

Smooth muscle contraction

Answer

Activates Plasmin formation

Question 3

Which of the following anticoagulants is given orally?

Accepted Answer

Rivaroxaban

Answer

Argatraban

Answer

Alteplase

Answer

Fondaparinux

Question 4

Which of the following is a parenteral direct thrombin inhibitor?

Accepted Answer

Argatroban

Answer

Ximelagatran

Answer

Dabigatran

Answer

Heparin

Question 5

What is Hydroxyethyl starch?

Accepted Answer

Plasma expander

Answer

Vasodilator

Answer

Inotrope

Answer

Diuretic

Question 6

The best agent for increasing HDL cholesterol is?

Accepted Answer

Nicotinic acid

Answer

Statin

Answer

Gugulipids

Answer

Fibrates

Question 7

Which drug is used as a treatment for sickle cell anemia by promoting fetal hemoglobin production?

Accepted Answer

Hydroxyurea

Answer

Trypsin

Answer

L-glutamine

Answer

Glucose 6-phosphate dehydrogenase

Question 8

Low molecular weight heparin mainly inhibits which factor?

Accepted Answer

Factor Xa

Answer

Factor VIIIa

Answer

Factor XIIa

Answer

Factor IIa

Question 9

Romiplostim mimics which of the following receptors?

Accepted Answer

Thrombopoietin

Answer

IL 6

Answer

IL 8

Answer

PGE 1

Question 10

Which of the following drugs inhibit platelet cyclooxygenase reversibly?

Accepted Answer

Ibuprofen

Answer

Alprostadil

Answer

Prednisolone

Answer

Aspirin

Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation — MCQs

On this page

Practice by Chapter

Want unlimited practice?